Navigation Links
OrPro Therapeutics Receives NIH Grant Award to Advance Development of Recombinant Thioredoxin for Treatment of Cystic Fibrosis
Date:7/31/2012

r, CO by pediatric pulmonologist Dr. Carl White, M.D.  In 2011, OrPro licensed from NJH an intellectual property portfolio claiming compositions and uses of the thioredoxin active site for the treatment of pulmonary disease.  Dr. White (now at University of Colorado Denver/Children's Hospital Colorado), and his NJH colleague Dr. David Nichols are medical advisors to the company, and will collaborate on the NIH-funded project. 

"We have assembled a world-class team of experts in research, preclinical/clinical development, biologics manufacturing, and finance to help guide OrPro in the development of this exciting new product candidate," said Heifetz, who is also principal investigator on the SBIR grant. "We believe the support from NIH will act as a catalyst for the company and we look forward to completing an initial round of financing to accelerate our development efforts."

About OrPro

OrPro Therapeutics, Inc. is a pre-clinical stage biopharmaceutical company headquartered in San Diego, CA. The company's goal is to develop a breakthrough class of safe, well-tolerated and more effective inhaled non-systemic drugs based on the thioredoxin active site for the treatment of patients with cystic fibrosis (CF), COPD/emphysema, bronchiectasis, severe asthma, and other serious obstructive pulmonary diseases. These diseases are characterized by thickened mucus resulting in impaired lung function. Poor clearance of abnormal, sticky mucus is associated with chronic infection and premature death, especially in CF. Despite advances in antibiotic therapy and other treatments there remains a large unmet medical need for improved mucus-reducing (mucolytic) drugs which in many cases are the most efficacious means of mitigating disease symptoms. Effective new treatments for CF are forecast to achieve peak annual sales in excess of $1 billion annually. OrPro's lead product, ORP-100, an aerosolized variant of recombinant human thioredoxin, wil
'/>"/>

SOURCE OrPro Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
2. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
3. Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers
4. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
5. PTC Therapeutics Closes $30 Million Financing
6. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
7. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
8. Echo Therapeutics Expands License Agreement with Ferndale Pharma
9. PTC Therapeutics Announces Achievement of Major Milestone in Wellcome Trust BMI1 Collaboration
10. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
11. NIPTE Will Participate in NIHs Therapeutics for Rare and Neglected Diseases (TRND) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)...  A substantial share of pharmacy and therapeutics ... are included in formularies—say patient support resources from ... Manhattan Research study, Taking the Pulse® Formulary ... P&T committee members in hospitals, managed care organizations ... a high bar for these programs, requiring that ...
(Date:7/31/2014)... Lazarus Effect, a medical device company focused ... removal of blood clots, announced the closing of a ... EU commercialization of several approved Lazarus Effect devices, as ... Lazarus Cover™ in the United States ... the value of our novel, platform technology as well ...
(Date:7/31/2014)... , July 31, 2014 For its innovative ... California , Art,s-Way Scientific has earned a Modular ... With competition in over 30 categories, MBI,s contest is ... members, which include building manufacturers, dealers, and product and ... excellent example the capability of our team," said ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Lazarus Effect Closes $5 Million Financing 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... , SAN MATEO, Calif., Oct. 1 Corthera Inc. ... (FDA) has granted Fast Track designation to relaxin, the ... failure (AHF). The Fast Track program facilitates the development ... treat serious or life-threatening conditions and that demonstrate the ...
... Oct. 1 Health Strategies Group, a leading ... industries, has just launched Oncology Performance Edge, a new ... in the oncology field improve brand performance by understanding ... oncology market is significantly different from others, with unique ...
Cached Medicine Technology:Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure 2Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure 3Health Strategies Group Introduces Oncology Performance Edge 2Health Strategies Group Introduces Oncology Performance Edge 3
(Date:7/31/2014)... United Theological Seminary is pleased to welcome two ... Peter J. Bellini. Both began their teaching duties on ... Director of Non-Degree Programs, Mark Abbott, who begins his ... Assistant Professor of New Testament, received a Ph.D. from ... Temple Judaism, and Greek courses. His research interests are ...
(Date:7/31/2014)... July 31, 2014 Cosmetic Town is ... Plastic Surgeons to consumers considering cosmetic treatments. The ... peers whose goal is to educate prospective patients on ... selected through a validated referral system that helps patients ... best in their respective fields. , Cosmetic Town ...
(Date:7/31/2014)... The VitaSleep FDA cleared anti-snoring ... provide an easier breathing capacity by slightly adjusting the ... people can breathe easier and helps reduce or even ... that it can meet the needs of each individual ... shared by actual customer reviews. Johathan R. from ...
(Date:7/31/2014)... Miami, FL (PRWEB) July 31, 2014 ... (LMS) which continues to help healthcare agencies to ... help companies and agencies meet their accreditation ... with competency based training. , Healthcare administrators ... a few clicks of the mouse. Courses can ...
(Date:7/31/2014)... Andrie, Inc. V. Dept. of Treasury, Mich. S. Ct., ... made the determination that a purchaser of tangible goods in ... unable to prove during an audit that sales tax ... of Appeals decision on whether a purchaser bears the burden ... from Michigan sellers. The Court states “in order to be ...
Breaking Medicine News(10 mins):Health News:Growing Seminary Welcomes New Faculty 2Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 2Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 3Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3
... group of scientists, led by mathematicians, has taken on ... responses. Their work will radically improve our understanding of ... disciplines working on it to have a common reference ... and Biological Sciences Research Council (BBSRC), will investigate how ...
... Researchers have identified which sites and cell types ... avian influenza viruses, providing valuable insights into the pathogenesis ... et al, Human and avian influenza viruses target different ... other mammals, appears in the October issue of The ...
... Grants Initiative to Support Hundreds of Research Projects ... Involving Scientists Around the World, ... Melinda,Gates Foundation announced today that it is committing $100 million ... support,innovative global health research. The initiative,s goal is to encourage,scientists ...
... Oct. 9 Medical Simulation Corporation (MSC) ... with the Methodist DeBakey Heart,Center in Houston ... help Methodist cardiologists and surgeons improve patient,safety ... update surgical and,interventional skills in a simulated, ...
... Available at ... PhillyHealthInfo.org, PHILADELPHIA, Oct. 9 PhillyHealthInfo is the ... Chester,Delaware, and Montgomery counties. Go to http://www.PhillyHealthInfo.org ,for this season,s flu ... Where to go for free or low cost flu shots. -- ...
... Experiences and sanofi-aventis, Goal to be Part of ... Among Stakeholders, LITTLE ROCK, Ark., Oct. 9 ... at the Collaborative Practice Summit (CPS) hosted by the ... in Uncasville,Conn. CPS brought together a focused group ...
Cached Medicine News:Health News:Mathematicians help unlock secrets of the immune system 2Health News:Influenza: Insights into cell specificity of human vs. avian viruses 2Health News:Gates Foundation Launches $100 Million Initiative to Spur Innovation in Global Health Research 2Health News:Gates Foundation Launches $100 Million Initiative to Spur Innovation in Global Health Research 3Health News:Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston 2Health News:Sanofi-aventis US Chairman Tim Rothwell Addresses CMSA's Collaborative Practice Summit 2Health News:Sanofi-aventis US Chairman Tim Rothwell Addresses CMSA's Collaborative Practice Summit 3Health News:Sanofi-aventis US Chairman Tim Rothwell Addresses CMSA's Collaborative Practice Summit 4
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
The cath lab blanket, designed for use in the Cardiac Cath Lab, surrounds the patient with warm air and allows unrestricted access to the femoral artery....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: